Neutropenia due to Clopidogrel in a Patient with End-Stage Renal Disease-Reference-Cited by-同舟云学术

Neutropenia due to Clopidogrel in a Patient with End-Stage Renal Disease

Published:2004-09 Issue:9 Volume:38 Page:1538-1539
ISSN:1060-0280
Container-title:Annals of Pharmacotherapy
language:en
Short-container-title:Ann Pharmacother

Author:

Akcay Ali¹,Kanbay Mehmet²,Agca Erhan³,Sezer Siren⁴,Ozdemir Fatma Nurhan⁵

Affiliation:

1. Fellow of Nephrology Divisions of Nephrology Department of Internal Medicine Faculty of Medicine Baskent University Oguzlar Mahallesi 35. Sokak, No: 17/7 Balgat 06520 Ankara, Turkey fax 90 312 213 00 34

2. Resident in Internal Medicine Divisions of Nephrology Department of Internal Medicine Faculty of Medicine Baskent University

3. Fellow of Nephrology Divisions of Nephrology Department of Internal Medicine Faculty of Medicine Baskent University

4. Associate Professor of Nephrology Divisions of Nephrology Department of Internal Medicine Faculty of Medicine Baskent University

5. Professor of Nephrology Divisions of Nephrology Department of Internal Medicine Faculty of Medicine Baskent University

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Link

http://journals.sagepub.com/doi/pdf/10.1345/aph.1E119

Reference5 articles.

1. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)

2. Fatal aplastic anaemia associated with clopidogrel

3. Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel

4. Febrile Pancytopenia Associated With Clopidogrel

5. A method for estimating the probability of adverse drug reactions

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clopidogrel-induced neutropenia in an 80-year-old patient with chronic kidney disease who underwent percutaneous coronary intervention: a case report and literature review;BMC Cardiovascular Disorders;2022-02-11

2. Anticoagulants;Cutaneous Drug Hypersensitivity;2022

3. DNA Damage in AML-12 Hepatocytes and 3T3-L1 Adipocytes Treated with Clopidogrel;Current Drug Safety;2021-11-30

4. Clopidogrel Hypersensitivity: Pathogenesis, Presentation and Diagnosis;Current Vascular Pharmacology;2019-01-09

5. A joint allergist/cardiologist classification for thienopyridines hypersensitivity reactions based on their symptomatic patterns and its impact on the management strategies;International Journal of Cardiology;2016-11